{
    "title": "U.S.FDA panel votes against Veru's COVID-19 pill",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11409753/U-S-FDA-panel-votes-against-Verus-COVID-19-pill.html",
    "date": "2022-11-09",
    "keywords": [
        "panel",
        "drug",
        "covid19",
        "treatment",
        "bhanvi",
        "satija",
        "raghav",
        "mahobe",
        "regulator",
        "veru",
        "sample",
        "data",
        "member",
        "authorization",
        "sabizabulin",
        "study",
        "health",
        "wednesday",
        "highrisk",
        "efficacy",
        "safety",
        "trial",
        "ability",
        "entity",
        "evidence",
        "activity",
        "susanne",
        "vote",
        "setback",
        "effort",
        "company",
        "tumor",
        "prostate",
        "cancer",
        "food",
        "administration",
        "staff",
        "application",
        "latestage",
        "size",
        "meeting",
        "lack",
        "clarity",
        "patient",
        "population",
        "rate",
        "placebo",
        "group",
        "promise",
        "future",
        "representative",
        "jennifer",
        "schwartzott",
        "fda",
        "pill",
        "option",
        "disease",
        "pandemic",
        "stage",
        "reporting",
        "bengaluru",
        "editing",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}